The occurrence of flare-up of systemic lupus erythematosus (SLE) in relation to use of oral contraceptives was studied in 85 SLE patients of 2 rheumatology clinics at the Helsinki University Central Hospital Helsinki Finland from interviews taken from March 1989-April 1990. 37 (44%) ever used ...
The metabolic effects of a new oral contraceptive Femodene (SHD 356C) containing 75 渭g gestodene (螖-15-levonorgestrel) and 30 渭g ethinyloestradiol were studied in two groups of women. Group 1 consisted of women not currently using oral contraceptives; Group 2 consisted of women switching ...
Luteinising hormone, oestradiol and progesterone were measured in 36 women commencing Femodene contraception on the first day of menstruation. Of these subjects, 17 were not on any oral contraception during the preceding cycle, the remaining 19 changing from another oral contraceptive formulation. Full...
gestodene (femovan \\/ femodene)DELTA 15-Steroids of the formula wherein R1 is a hydrogen atom, trialkylsilyl or acyl; R2 is ethynyl, chloroethynyl or propinyl; and X is an oxygen atom, or NOR4 wherein R3 is a hydrogen atom or acyl and R4 is a hydrogen atom, acyl, alkyl ...
The present invention provides a contraceptive kit which helps to solve or improve puncture and spot bleeding problems associated with estrogen contraceptives lowest dose (15-20μg EE).G·S·格鲁布